Keio University

News

321-330 items (total 701)
Published At March 29, 2023

Olfactory Training Device "yokun" Wins Multiple International Design Awards—A KGRI and Keio SDM Joint Research Project

Public Relations Office

Published At March 27, 2023

The Faculty of Policy Management Publishes the "Sogo Seisaku Gaku wo Hiraku" (Opening Up Policy Management) Series in Five Volumes

Public Relations Office

Published At March 23, 2023

[Press Release and Video Release] Launch of the KGRI Centre for Strategy (March 1, 2023) and more

KGRI

Published At March 23, 2023

Elucidating the Exciton Multiplication Process that Dynamically Changes with Pressure—Achieving Hydrostatic Pressure Control of Intramolecular Singlet Fission

Public Relations Office

Published At March 22, 2023

Hydrogen Inhalation Therapy Effective in Saving Lives and Improving Prognosis for Out-of-Hospital Cardiac Arrest Patients: Report on Clinical Trial Results from Emergency Medical Institutions Nationwide

Public Relations Office

Published At March 16, 2023

New Method Developed to Evaluate the Efficacy of Poorly Absorbed Antimicrobial Agents- Contributing to the Proper Use of Therapeutics for Clostridioides difficile Infection and Promoting the Development of New Treatments -

Public Relations Office

Published At March 16, 2023

Proposal of a Bio-Inspired Molecular-Scale Water Transport Method: Toward the Construction of an Ultra-Low Energy Water Transport System

Public Relations Office

Published At March 15, 2023

"1stRound," Japan's Largest Technology Seed Commercialization Program, Expands to 13 Co-sponsoring Universities and Renews Brand Design—Kyushu University, Keio University, Ritsumeikan University, Ritsumeikan Asia Pacific University, and Waseda University Join

Public Relations Office

Published At March 14, 2023

Which Patients Benefit from New Migraine Drugs (CGRP-related Monoclonal Antibodies)? - The First Paper from Japan -

Public Relations Office

Published At March 14, 2023

Report on the Results of the First Nationwide Epidemiological Survey of MOG Antibody-Associated Disease, a Central Nervous System Autoimmune Disease—Aiming for Designation as an Intractable Disease and Development of Treatments

Public Relations Office